BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33511941)

  • 21. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
    Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
    Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coumarin derivatives with anticancer activities: An update.
    Song XF; Fan J; Liu L; Liu XF; Gao F
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000025. PubMed ID: 32383190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies.
    Abd El-Karim SS; Syam YM; El Kerdawy AM; Abdelghany TM
    Bioorg Chem; 2019 May; 86():80-96. PubMed ID: 30685646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.
    Wu XQ; Huang C; Jia YM; Song BA; Li J; Liu XH
    Eur J Med Chem; 2014 Mar; 74():717-25. PubMed ID: 24119869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide - A new caspase-activating proapoptotic agent.
    Dar'in D; Kantin G; Kalinin S; Sharonova T; Bunev A; Ostapenko GI; Nocentini A; Sharoyko V; Supuran CT; Krasavin M
    Eur J Med Chem; 2021 Oct; 222():113589. PubMed ID: 34147910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies.
    Kamath PR; Sunil D; Ajees AA; Pai KS; Das S
    Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, Synthesis, and Antiproliferative Evaluation of Novel Coumarin/2-Cyanoacryloyl Hybrids as Apoptosis Inducing Agents by Activation of Caspase-Dependent Pathway.
    Zhang YY; Zhang QQ; Song JL; Zhang L; Jiang CS; Zhang H
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30087276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
    Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
    Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of new coumarins bearing 2,4-diaminothiazole-5-carbonyl moiety.
    Ayati A; Oghabi Bakhshaiesh T; Moghimi S; Esmaeili R; Majidzadeh-A K; Safavi M; Firoozpour L; Emami S; Foroumadi A
    Eur J Med Chem; 2018 Jul; 155():483-491. PubMed ID: 29908441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiokinase inhibition of VEGFR-2, PDGFR and FGFR and cell growth inhibition in lung cancer: Design, synthesis, biological evaluation and molecular docking of novel azaheterocyclic coumarin derivatives.
    Ahmed EY; Elserwy WS; El-Mansy MF; Serry AM; Salem AM; Abdou AM; Abdelrahman BA; Elsayed KH; Abd Elaziz MR
    Bioorg Med Chem Lett; 2021 Sep; 48():128258. PubMed ID: 34246754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors.
    Ji H; Tan Y; Gan N; Zhang J; Li S; Zheng X; Wang Z; Yi W
    Bioorg Med Chem; 2021 Jan; 29():115870. PubMed ID: 33221062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human estrogen receptor α antagonists, part 2: Synthesis driven by rational design, in vitro antiproliferative, and in vivo anticancer evaluation of innovative coumarin-related antiestrogens as breast cancer suppressants.
    Kurtanović N; Tomašević N; Matić S; Mitrović MM; Kostić DA; Sabatino M; Antonini L; Ragno R; Mladenović M
    Eur J Med Chem; 2022 Jan; 227():113869. PubMed ID: 34710747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current developments of coumarin-based anti-cancer agents in medicinal chemistry.
    Emami S; Dadashpour S
    Eur J Med Chem; 2015 Sep; 102():611-30. PubMed ID: 26318068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coumarins as Potential Anti-drug Resistant Cancer Agents: A Mini Review.
    Wang G; Sun S; Wu B; Liu J
    Curr Top Med Chem; 2021; 21(19):1725-1736. PubMed ID: 33185162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
    Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-breast Cancer Potential of Natural and Synthetic Coumarin Derivatives.
    Song F; Huo X; Guo Z
    Curr Top Med Chem; 2021; 21(18):1692-1709. PubMed ID: 33655862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coumarin Derivatives as Anti-inflammatory and Anticancer Agents.
    Thomas V; Giles D; Basavarajaswamy GPM; Das AK; Patel A
    Anticancer Agents Med Chem; 2017; 17(3):415-423. PubMed ID: 27592545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
    Cao D; Liu Y; Yan W; Wang C; Bai P; Wang T; Tang M; Wang X; Yang Z; Ma B; Ma L; Lei L; Wang F; Xu B; Zhou Y; Yang T; Chen L
    J Med Chem; 2016 Jun; 59(12):5721-39. PubMed ID: 27213819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.